MCS+: payments to doctors
Payments that named MCS+ as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Haemonetics Corporation?
Haemonetics Corporation reported the most payments naming MCS+. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $17K
- Providers
- 1
- Transactions
- 3
- Average per transaction
- $5,627
The per-transaction average — $5,627 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1 providers the average total is $16,880, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Haemonetics Corporation | $16,880 | 100.0% |
Other products from Haemonetics Corporation
The company that reported the most payments naming MCS+ also reports against these.
- TEG6s HEMOSTASIS SYSTEM$851,804
- TEG$629,231
- Plasma$521,132
- BloodTrack$489,452
- Cell Saver$433,324
- TEG5000 Hemostasis Analyzer$329,507
- HAEMONETICS CELL SAVER ELITE+ SYSTEM$163,477
- TEG Manager$83,038
- HAEMONETICS MCS+ (LN9000) APHERESIS SYSTEM$81,914
- HAEMONETICS NEXSYS PCS SYSTEM$54,000